Home - Sense Neuro Diagnostics

When treating stroke and brain injury, time to proper treatment is critical. Time is brain.

Sense is developing non-invasive technology enabling rapid, comprehensive detection of stroke subtype + TBI, and continuous brain injury monitoring.

NEWS

FOX19 Highlights Sense Neuro Diagnostics’ Initiatives in Rapid Brain Injury Detection

NEWS | Nov 19, 2025FOX19 Highlights Sense Neuro Diagnostics’ Initiatives in Rapid Brain Injury DetectionSense Neuro Diagnostics was recently featured by FOX19 in a segment with one of our co-founders, Dr. George “Chip” Shaw. Dr. Shaw discussed our ongoing efforts to...

The Need

There is no accurate, objective way to detect stroke subtype or brain hemorrhage in a field environment or to monitor ongoing brain injury continuously, non-invasively and in real time.

In the field, triage to the correct care facility is critical to avoid disability and death caused by delays in treatment.

Medical personnel must rely on an amalgam of information – clinical exams, vital signs, implanted ICP monitors – to determine whether the brain is bleeding between CT/MRI scans.

Our Solution

Non-invasive brain scanners that will assess and monitor the neurological status of a patient in real time.

Field Assessment for military use

In development

Rapid triage and assessment for emergency departments and ambulance use

In development

Continuous Hospital Monitoring

Clinical trials have begun for submission to the FDA to obtain clearance for commercial launch. Hope to receive clearance by the end of 2024.

In just 2.5 seconds, our devices scan the entire cranial vault

Nine antennae alternate transmitting and receiving a safe, low-power radio frequency (RF) pulse across the patient’s brain. Healthy brain tissues have unique electrical properties that alter the RF wave as it passes through the tissue. Similarly, hemorrhages and ischemic tissue cause distinctive changes to the RF signal.

Find out more about our technology

Functionality of Sense Technology

Single scan in 2.5 seconds

360 data points per scan

Analyzes the entire cranial vault

Sense is developing technology to differentiate between:

Stroke

Intracerebral hemorrhage (ICH)
Large vessel occlusion (LVO)
Non LVO

Traumatic Brain Injury

Intracerebral hemorrhages

Clinical Evidence for Sense Technology

An FDA pivotal trial of our hospital monitoring device is underway at multiple sites, following promising first-in-human pilot studies and foundational research.

Find out more

Experienced Leadership Team

Our leadership team includes seasoned health care executives, entrepreneurs, innovators, and our medical co-founders – specialists in emergency medicine, neurology and neurocritical care working to improve patient outcomes through rapid detection and better triage of stroke and brain injury.

Meet our team

Contact Us

To learn more about Sense Neuro products or communicate with our team, please provide your contact information. We will keep you up-to-date on our launch in your market area.

Pending FDA De Novo review. Device not yet cleared for clinical use.

info@senseneuro.com
6037 Schumacher Park Dr,
West Chester, OH 45069
Privacy Policy

We're social:

External links are provided for informational purposes only. Sense Neuro Diagnostics does not control or endorse third-party content.

NeuroHawk™ is an investigational device and is not yet cleared or approved by the U.S. Food and Drug Administration (FDA). It is not available for sale or clinical use in the United States. Information provided is for educational and investor purposes only.